Classification of Psychodermatological Disorders: Proposal of a New International Classification

    Bárbara Roque Ferreira, Nienke Vulink, Ladan Mostaghimi, Mohammad Jafferany, Flora Balieva, Uwe Gieler, F. Poot, Adam Reich, Д. В. Романов, Jacek C. Szepietowski, Lucía Tomás-Aragonés, Ricardo Campos, Francisco Tausk, Marie Zipser, Anthony Bewley, Laurent Miséry
    Image of study
    TLDR The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.
    The document proposes a new international classification for psychodermatological disorders, which are conditions that involve both the skin and the mind. The authors argue that current classifications are inconvenient and cause confusion. The new classification, approved by the EADV Psychodermatology Task Force, ESDaP, and APMNA, divides these disorders into two main groups: 'primary mental health disorders affecting the skin' and 'primary skin disorders linked with mental health'. The first group includes disorders like trichotillomania (hair pulling) and trichophagia (compulsive eating of pulled hairs), while the second group includes disorders like alopecia areata and androgenetic alopecia. The document also discusses the importance of correct terminology and the need for further research in this field.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    3 / 3 results

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  146 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Related Research

    1 / 1 results